Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Int Immunopharmacol. 2012 Nov 14;15(1):67–72. doi: 10.1016/j.intimp.2012.10.019

Figure 3. Memory CTLs from peptide boosts with TLR-L adjuvants are protective against challenge with LM-OVA.

Figure 3

Splenocytes containing 105 memory (M4) or naïve OT-I cells were transferred into naïve B6 mice, which were challenged with 5×105 LM-OVA i.v. the next day. Spleens were harvested for LM-OVA counting three days after LM-OVA challenge. VV-OVA-primed memory mice (with OT-I transferred) were used as positive controls. Each group was compared to the naïve OT-I transferred group.